Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Reexamination Certificate
2007-02-27
2007-02-27
Robinson, Hope (Department: 1652)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
C435S006120, C435S007100, C536S023100, C530S350000, C530S300000, C514S002600, C514S012200
Reexamination Certificate
active
10893995
ABSTRACT:
Human chemokine polypeptides and DNA (RNA) encoding such chemokine polypeptides and a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such chemokine polypeptides for the treatment of leukemia, tumors, chronic infections, autoimmune disease, fibrotic disorders, wound healing and psoriasis. Antagonists against such chemokine polypeptides and their use as a therapeutic to treat rheumatoid arthritis, autoimmune and chronic inflammatory and infective diseases, allergic reactions, prostaglandin-independent fever and bone marrow failure are also disclosed. Diagnostic assays for identifying mutations in nucleic acid sequence encoding a polypeptide of the present invention and for detecting altered levels of the polypeptide of the present invention are also disclosed.
REFERENCES:
patent: 4897348 (1990-01-01), Johnson et al.
patent: 5011912 (1991-04-01), Hopp et al.
patent: 5278287 (1994-01-01), Rollins et al.
patent: 5306709 (1994-04-01), Gewirtz
patent: 5346686 (1994-09-01), Lyle et al.
patent: 5413778 (1995-05-01), Kunkel et al.
patent: 5474983 (1995-12-01), Kuna et al.
patent: 5602008 (1997-02-01), Wilde et al.
patent: 5936068 (1999-08-01), Wilde et al.
patent: 6096300 (2000-08-01), Hromas
patent: 6174995 (2001-01-01), Li et al.
patent: 0538 030 2 (1993-04-01), None
patent: 07-089866 (1995-04-01), None
patent: WO-90/06321 (1990-06-01), None
patent: WO-91/04274 (1991-04-01), None
patent: WO-91/12815 (1991-09-01), None
patent: WO-92/05198 (1992-04-01), None
patent: WO-92/20372 (1992-11-01), None
patent: WO-95/17092 (1995-06-01), None
patent: WO-95/31467 (1995-11-01), None
patent: WO-95/31468 (1995-11-01), None
patent: WO-96/05856 (1996-02-01), None
patent: WO-96/06169 (1996-02-01), None
patent: WO-96/09062 (1996-03-01), None
patent: WO-96/16979 (1996-06-01), None
patent: WO-96/39520 (1996-12-01), None
patent: WO-96/39521 (1996-12-01), None
patent: WO-96/39522 (1996-12-01), None
patent: WO-97/31098 (1997-03-01), None
patent: WO-97/15594 (1997-05-01), None
patent: WO-97/15595 (1997-05-01), None
patent: WO-97/35982 (1997-10-01), None
patent: WO-98/01557 (1998-01-01), None
patent: WO-98/09171 (1998-03-01), None
patent: WO-98/11226 (1998-03-01), None
patent: WO-98/14573 (1998-04-01), None
patent: WO-98/17800 (1998-04-01), None
patent: WO-98/21330 (1998-05-01), None
patent: WO-99/47674 (1999-09-01), None
Wells, Biochemistry, vol. 29, pp. 8509-8517, 1990.
Seffernick et al., J. Bacteriology, vol. 183, pp. 2405-2410, 2001.
GenBank Accession No. I35613 (1997).
GenBank Accession No. AAB38703 (1996).
GenBank Accession No. U77035 (1997).
GenBank Accession No. CAA66950 (1998).
GenBank Accession No. U46767 (1997).
GenBank Accession No. D86955 (1997).
GenBank Accession No. X98306 (1998).
GeneSeq Accession No. W17660 (1997).
GeneSeq Accession No. R95690 (1996).
GeneBank Accession No. U64197 (1997).
GeneSeq Accession No. W44398 (1998).
GeneSeq Accession No. W61279 (1998).
GeneSeq Accession No. W57475 (1998).
GeneSeq Accession No. T90880 (1998).
GeneSeq Accession No. V28591 (1998).
GeneSeq Accession No. T90883 (1998).
GeneBank Accession No. W30191 (1998).
GenBank Accession No. AAC50943.1 (Aug. 6, 1996).
GenBank Accession No. AAB61534.1 (Aug. 6, 1996).
GenBank Accession No. AA739063 (Jan. 14, 1998).
GenBank Accession No. T27336 (Dec. 6, 1994).
GenBank Accession No. AI735669 (Jun. 14, 1999).
GenBank Accession No. T27433 (Dec. 6, 1994).
GenBank Accession No. D31065 (Feb. 8, 1995).
GenBank Accession No. AA297433 (Apr. 18, 1997).
GenBank Accession No. AJ001634 (Sep. 10, 1997).
GenBank Accession No. AJ000979 (Jun. 30, 1997).
GenBank Accession No. AC002482 (Aug. 21, 1997).
GenBank Accession No. Z77650 (Jul. 30, 1996).
GenBank Accession No. Z77651 (Jul. 30, 1996).
GenBank Accession No. CAA04888 (Sep. 10, 1997).
GenBank Accession No. CAB01111 (Jul. 30, 1996).
GenBank Accession No. CAB01112 (Jul. 30, 1996).
GenBank Accession No. AI925360 (Jul. 30, 1999).
GenBank Accession No. AA403048 (Apr. 29, 1997).
GenBank Accession No. AA404346 (Apr. 30, 1997).
GenBank Accession No. AA426245 (May 19, 1997).
GenBank Accession No. T64134 (Feb. 17, 1995).
GenBank Accession No. T64262 (Feb. 17, 1995).
GenBank Accession No. D17181 (Jul. 21, 1993).
GeneSeq Accession No. AAR93087 (1994).
GeneSeq Accession No. AAW22670 (1996).
GeneSeq Accession No. AAW56087 (1996).
GeneSeq Accession No. AAW56690 (1996).
GeneSeq Accession No. AAR29479 (1991).
Adema et al., “A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells,”Nature387:713-717 (Jun. 1997).
Berger, M.S., “Isolation of Monocyte Chemotactic Protein-4,”Clinical Res.42(2):305A (1994).
Bischoff et al., “Monocyte Chemotactic Protein 1 Is a Potent Activator of Human Basophils,”J. Exp. Med.175:1271-1275 (May 1992).
Blum et al., “Three Human Homologs of a Murine Gene Encoding an Inhibitor of Stem Cell Proliferation,”DNA and Cell Biol.9(8)589-602 (1990).
Brown et al., “A Family of Small Inducible Proteins Secreted by Leukocytes are Members of a New Superfamily that Includes Leukocyte and Fibroblast-Derived Inflammatory Agents, Growth Factors, and Indicators of Various Activation Processes,”J. Immunol.142(2):679-687 (Jan. 15, 1989).
Clements et al., “Biological and Structural Properties of MIP-1a Expressed in Yeast,”Cytokine4(1):76-82 (Jan. 1992).
Craddock et al., “Antibodies to VLA4 integrin mobilize long-term repopulating cells and augment cytokine-induced mobilization in primates and mice,”Blood(90(12):4779-4788 (Dec. 15, 1997).
Derynck et al., “Recombinant Expression, Biochemical Charcterization, and Biological Activities of Human MGSA/gro Protein,”Biochem.29(44):10225-10233 (1990).
Furuta et al., “Production and Characterization of Recombinant Human Neutrophil Chemotactic Factor,”J. Biochem.106:436441 (1989).
Garcia-Zepeda et al., “Human monocyte chemoattractant protein (MCP)-4 is a novel CC chemokine with activities on monocytes, eosinophils, and basophils induced in allergic and nonallergic inflammation that signals through the CC chemokine receptors (CCR)-2 and -3,”J. Immunol.157(12):5613-5626 (Dec. 15, 1996).
George et al., “Current Methods in Sequence Comparison and Analysis, Macromolecular Sequencing & Synthesis,”Alan R. Liss, Inc.12:127-149 (1988).
Glover, David M., “Gene Cloning,”Chapman and Hall(1984).
Graham et al., “SCI/MIP-1a: A Potent Stem Cell Inhibitor with Potential Roles in Development,”Develop. Biol.151:377-381 (1992).
Hieshima et al., “A Novel Human CC Chemokine PARC That Is Most Homologous to Macrophage-Inflammatory Protein-1a/LD78a and Chemotactic for T Lymphocytes, but Not for Monocytes,”J. Immunol.159:1140-1149 (1997).
Hieshima et al., “Molecular Cloning of a Novel Human CC Chemokine Liver and Activation-regulated Chemokine (LARC) Expressed in Liver,”J. Biol. Chem.272(9):5846-5853 (Feb. 28, 1997).
Hromas et al., “Cloning and Characterization of Exodus, a Novel β-Chemokine,”Blood89(9):3315-3322 (1997).
Jose et al., “Eotaxin: A Potent Eosinophil Chemoattractant Cytokine Detected in a Guinea Pig Model of Allergic Airways Inflammation,”J. Exp. Med.179: 881-887 (Mar. 1994).
Kodelja et al., “Alternative Macrophage Activation-Associated CC-Chemokine-1, a Novel Structural Homologue of Macrophage Inflammatory Protein-1a with a TH2-Associated Expression Pattern,”J. Immunol.160(3):1411-1418 (Feb. 1, 1998).
Kuna et al., “Monocyte Chemotactic and Activating Factor Is a Potent Histamine-releasing Factor for Human Basophils,”J. Exp. Med.175:489-493 (Feb. 1992).
Kurdowska et al., “Biological and Kinetic Characterization of Recombinant Human Macrophage Inflammatory Peptides 2 Alpha and Beta and Comparison with the Neutrophil Activating Peptide 2 and Interleukin 8,”Cytokine6(2):124-134 (Mar. 1994).
Kwon et al., “cDNA sequences of two inducible T-cell genes,”PNAS USA86:1963-1967 (1989
Adams Mark D.
Li Haodong
Human Genome Sciences Inc.
Human Genome Sciences Inc.
Robinson Hope
LandOfFree
Human Ckβ-10 polynucleotides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human Ckβ-10 polynucleotides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human Ckβ-10 polynucleotides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3827458